Hony Capital trims CSPC Pharma stake

Private equity firm Hony Capital raised $484 million after selling 10% of its shares in CSPC Pharma in an accelerated block in Hong Kong.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES